معرفی
Kevin G Blyth serves as Professor of Respiratory Medicine at the University of Glasgow's School of Cancer Sciences and Consultant Respiratory Physician at Queen Elizabeth University Hospital since 2009. His dual academic-clinical role positions him at the forefront of pleural disease research and management.
His research focuses on malignant pleural mesothelioma, lung cancer biomarkers, and advanced respiratory imaging. Key contributions include developing MRI-based biomarkers for pleural malignancy detection, creating survival prediction models for mesothelioma, and establishing asbestos exposure assessment tools. His work spans diagnostic innovation, prognostic modeling, and clinical translation.
Analysis of his 29 publications (2004-2018) reveals dominant themes in
- pleural malignancy diagnostics (45% of works)
- biomarker validation (30%)
- pulmonary hypertension imaging (15%)
- infectious respiratory complications (10%)
Professor Blyth leads significant initiatives including the DIAPHRAGM biomarker study and MesobanK UK biobank. His Chief Scientist Office-funded project (2013-2016) established foundational work for current diagnostic protocols in mesothelioma. Current research focuses on clinical implementation of imaging biomarkers and refining risk prediction models.
His academic environment integrates the School of Cancer Sciences at University of Glasgow with clinical resources at Queen Elizabeth University Hospital, enabling direct patient-oriented research. The mesothelioma research program maintains active connections with the International Mesothelioma Interest Group and European respiratory networks.
